Published in Arch Pathol Lab Med on April 17, 2015
Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA (2015) 1.38
Performance in Measurement of Serum Cystatin C by Laboratories Participating in the College of American Pathologists 2014 CYS Survey. Arch Pathol Lab Med (2016) 1.10
Detrimental Effects of Not Using International Reference Materials to Calibrate Cystatin C Assays. Clin Chem (2015) 1.05
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD. Am J Kidney Dis (2016) 0.85
The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol (2016) 0.81
Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis. Clin J Am Soc Nephrol (2016) 0.79
The impact of estimated glomerular filtration rate equations on chronic kidney disease staging in pediatric renal or heart transplant recipients. Pediatr Nephrol (2016) 0.77
In Reply. Arch Pathol Lab Med (2016) 0.75
In Reply. Clin Chem (2015) 0.75
Strategies for assessing GFR and albuminuria in the living kidney donor evaluation. Curr Transplant Rep (2017) 0.75
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med (2005) 5.78
Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. Am J Med Genet A (2006) 4.56
Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study. Aging Cell (2008) 3.24
Reporting estimated GFR: a laboratory perspective. Am J Kidney Dis (2008) 2.94
ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet (2004) 2.85
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med (2006) 2.81
Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol (2012) 2.75
Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol (2011) 2.50
Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis (2009) 2.43
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (2012) 2.42
Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2003) 2.41
Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem (2011) 2.34
Why commutability matters. Clin Chem (2006) 2.16
High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care (2010) 2.12
Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study. Circulation (2005) 2.03
Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem (2007) 1.88
Data mining and clinical data repositories: Insights from a 667,000 patient data set. Comput Biol Med (2005) 1.87
Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol (2009) 1.80
Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci (2003) 1.76
NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr (2010) 1.74
Biological variability of transferrin saturation and unsaturated iron-binding capacity. Am J Med (2007) 1.72
Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care. Diabetes Care (2010) 1.69
Genome scan of glomerular filtration rate and albuminuria: the HyperGEN study. Nephrol Dial Transplant (2006) 1.59
Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 2: free thyroxine and free triiodothyronine. Clin Chem (2010) 1.58
Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study. J Hypertens (2010) 1.55
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. Am J Kidney Dis (2013) 1.54
State of the art for measurement of urine albumin: comparison of routine measurement procedures to isotope dilution tandem mass spectrometry. Clin Chem (2013) 1.47
HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study. Circ Cardiovasc Genet (2009) 1.45
Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation (2003) 1.44
Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am J Clin Nutr (2011) 1.43
Biomarkers of folate status in NHANES: a roundtable summary. Am J Clin Nutr (2011) 1.43
Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 1: thyroid-stimulating hormone. Clin Chem (2010) 1.41
Alcohol consumption and metabolic syndrome: does the type of beverage matter? Obes Res (2004) 1.38
ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart. J Mol Cell Cardiol (2005) 1.38
Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and Jaffe method principles. Clin Chem (2011) 1.32
Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. JAMA (2008) 1.30
Discovery and fine mapping of serum protein loci through transethnic meta-analysis. Am J Hum Genet (2012) 1.29
Estimating glomerular filtration rate. Clin Chem Lab Med (2009) 1.29
Tandem function of nucleotide binding domains confers competence to sulfonylurea receptor in gating ATP-sensitive K+ channels. J Biol Chem (2002) 1.29
An investigation of the effects of lipid-lowering medications: genome-wide linkage analysis of lipids in the HyperGEN study. BMC Genet (2007) 1.27
Serum concentration of cystatin C and risk of end-stage renal disease in diabetes. Diabetes Care (2012) 1.26
HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study. Transl Res (2008) 1.20
Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can J Gastroenterol (2008) 1.19
A genome-wide affected sibpair linkage analysis of hypertension: the HyperGEN network. Am J Hypertens (2003) 1.12
Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study. Pharmacogenet Genomics (2008) 1.12
Serum ferritin and transferrin saturation in Asians and Pacific Islanders. Arch Intern Med (2007) 1.12
Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population. Clin J Am Soc Nephrol (2013) 1.11
Determining stability of stored samples retrospectively: the validation of glycated albumin. Clin Chem (2010) 1.08
Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study. Circulation (2013) 1.07
Familial clustering for features of the metabolic syndrome: the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study. Diabetes Care (2006) 1.06
The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Arch Intern Med (2004) 1.06
Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 3: total thyroxine and total triiodothyronine. Clin Chem (2010) 1.04
Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations. PLoS One (2012) 1.03
Liver diseases in the hemochromatosis and iron overload screening study. Clin Gastroenterol Hepatol (2006) 1.02
The importance of metrological traceability on the validity of creatinine measurement as an index of renal function. Clin Chem Lab Med (2006) 1.02
Genome-wide association study identifies genetic loci associated with iron deficiency. PLoS One (2011) 1.01
Dietary linolenic acid is inversely associated with plasma triacylglycerol: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr (2003) 1.01
Relation of the metabolic syndrome to calcified atherosclerotic plaque in the coronary arteries and aorta. Am J Cardiol (2005) 1.00
Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis (2003) 0.98
Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population. Am J Hematol (2008) 0.98
Comparison of two assays for serum 1,5-anhydroglucitol. Clin Chim Acta (2011) 0.97
Circulating soluble ICAM-1 levels shows linkage to ICAM gene cluster region on chromosome 19: the NHLBI Family Heart Study follow-up examination. Atherosclerosis (2007) 0.97
HAMP promoter mutation nc.-153C>T in 785 HEIRS study participants. Haematologica (2009) 0.97
Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke (2002) 0.96
Association study of CRP gene polymorphisms with serum CRP level and cardiovascular risk in the NHLBI Family Heart Study. Am J Physiol Heart Circ Physiol (2006) 0.95
Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study. Can J Gastroenterol (2009) 0.95
Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population. Clin Chem (2011) 0.94
HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants. Am J Hematol (2009) 0.94
Advances in standardization of laboratory measurement procedures: implications for measuring biomarkers of folate and vitamin B-12 status in NHANES. Am J Clin Nutr (2011) 0.94
Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum. Clin Chem Lab Med (2007) 0.94
Alcohol consumption and plasma atrial natriuretic peptide (from the HyperGEN study). Am J Cardiol (2006) 0.93
Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT. Int J Hypertens (2013) 0.92
Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants. Blood Cells Mol Dis (2009) 0.92
Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder. Clin Transplant (2012) 0.92
Measurement of free thyroxine in laboratory medicine--proposal of measurand definition. Clin Chem Lab Med (2007) 0.92
Serum β-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol (2012) 0.91
The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study. Pharmacogenet Genomics (2009) 0.91
A genome-wide screen reveals evidence for a locus on chromosome 11 influencing variation in LDL cholesterol in the NHLBI Family Heart Study. Hum Genet (2002) 0.91
Commutability still matters. Clin Chem (2013) 0.91
Interarm differences in seated systolic and diastolic blood pressure: the Hypertension Genetic Epidemiology Network study. J Hypertens (2005) 0.89
The effects of freeze-thaw on β-trace protein and β2-microglobulin assays after long-term sample storage. Clin Biochem (2012) 0.89
Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study. Hepatology (2012) 0.89
Harmonisation of Measurement Procedures: how do we get it done? Clin Biochem Rev (2012) 0.89
Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening. Am J Hematol (2008) 0.88
Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study. PLoS One (2013) 0.88
Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension. PLoS One (2011) 0.87
Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assays. Clin Chim Acta (2013) 0.86
Refined mapping of suggestive linkage to renal function in African Americans: the HyperGEN study. Am J Hum Genet (2002) 0.85
Dietary linolenic acid and fasting glucose and insulin: the National Heart, Lung, and Blood Institute Family Heart Study. Obesity (Silver Spring) (2006) 0.85
Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry. N Engl J Med (2015) 0.84
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study. Pharmacogenet Genomics (2012) 0.83